Literature DB >> 22619319

Plasmodium falciparum erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in children.

Thomas Lavstsen1, Louise Turner, Fredy Saguti, Pamela Magistrado, Thomas S Rask, Jakob S Jespersen, Christian W Wang, Sanne S Berger, Vito Baraka, Andrea M Marquard, Andaine Seguin-Orlando, Eske Willerslev, M Thomas P Gilbert, John Lusingu, Thor G Theander.   

Abstract

The clinical outcome of Plasmodium falciparum infections ranges from asymptomatic parasitemia to severe malaria syndromes associated with high mortality. The virulence of P. falciparum infections is associated with the type of P. falciparum erythrocyte membrane protein 1 (PfEMP1) expressed on the surface of infected erythrocytes to anchor these to the vascular lining. Although var2csa, the var gene encoding the PfEMP1 associated with placental malaria, was discovered in 2003, the identification of the var/PfEMP1 variants associated with severe malaria in children has remained elusive. To identify var/PfEMP1 variants associated with severe disease outcome, we compared var transcript levels in parasites from 88 children with severe malaria and 40 children admitted to the hospital with uncomplicated malaria. Transcript analysis was performed by RT-quantitative PCR using a set of 42 primer pairs amplifying var subtype-specific loci covering most var/PfEMP1 subtypes. In addition, we characterized the near-full-length sequence of the most prominently expressed var genes in three patients diagnosed with severe anemia and/or cerebral malaria. The combined analysis showed that severe malaria syndromes, including severe anemia and cerebral malaria, are associated with high transcript levels of PfEMP1 domain cassette 8-encoding var genes. Transcript levels of group A var genes, including genes encoding domain cassette 13, were also significantly higher in patients with severe syndromes compared with those with uncomplicated malaria. This study specifies the var/PfEMP1 types expressed in severe malaria in children, and thereby provides unique targets for future efforts to prevent and treat severe malaria infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22619319      PMCID: PMC3387094          DOI: 10.1073/pnas.1120455109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

1.  A sub-family of common and highly conserved Plasmodium falciparum var genes.

Authors:  Ali Salanti; Anja T R Jensen; Hanne D Zornig; Trine Staalsoe; Louise Joergensen; Morten A Nielsen; Ayman Khattab; David E Arnot; Mo Q Klinkert; Lars Hviid; Thor G Theander
Journal:  Mol Biochem Parasitol       Date:  2002-06       Impact factor: 1.759

2.  MUSCLE: multiple sequence alignment with high accuracy and high throughput.

Authors:  Robert C Edgar
Journal:  Nucleic Acids Res       Date:  2004-03-19       Impact factor: 16.971

3.  Indicators of life-threatening malaria in African children.

Authors:  K Marsh; D Forster; C Waruiru; I Mwangi; M Winstanley; V Marsh; C Newton; P Winstanley; P Warn; N Peshu
Journal:  N Engl J Med       Date:  1995-05-25       Impact factor: 91.245

4.  Antigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum.

Authors:  A Scherf; R Hernandez-Rivas; P Buffet; E Bottius; C Benatar; B Pouvelle; J Gysin; M Lanzer
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

5.  Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes.

Authors:  D I Baruch; B L Pasloske; H B Singh; X Bi; X C Ma; M Feldman; T F Taraschi; R J Howard
Journal:  Cell       Date:  1995-07-14       Impact factor: 41.582

6.  Evidence for the importance of genetic structuring to the structural and functional specialization of the Plasmodium falciparum var gene family.

Authors:  Susan M Kraemer; Joseph D Smith
Journal:  Mol Microbiol       Date:  2003-12       Impact factor: 3.501

7.  The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes.

Authors:  X Z Su; V M Heatwole; S P Wertheimer; F Guinet; J A Herrfeldt; D S Peterson; J A Ravetch; T E Wellems
Journal:  Cell       Date:  1995-07-14       Impact factor: 41.582

8.  Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria.

Authors:  Ali Salanti; Trine Staalsoe; Thomas Lavstsen; Anja T R Jensen; M P Kordai Sowa; David E Arnot; Lars Hviid; Thor G Theander
Journal:  Mol Microbiol       Date:  2003-07       Impact factor: 3.501

9.  Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes.

Authors:  J D Smith; C E Chitnis; A G Craig; D J Roberts; D E Hudson-Taylor; D S Peterson; R Pinches; C I Newbold; L H Miller
Journal:  Cell       Date:  1995-07-14       Impact factor: 41.582

10.  Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes.

Authors:  Anja T R Jensen; Pamela Magistrado; Sarah Sharp; Louise Joergensen; Thomas Lavstsen; Antonella Chiucchiuini; Ali Salanti; Lasse S Vestergaard; John P Lusingu; Rob Hermsen; Robert Sauerwein; Jesper Christensen; Morten A Nielsen; Lars Hviid; Colin Sutherland; Trine Staalsoe; Thor G Theander
Journal:  J Exp Med       Date:  2004-05-03       Impact factor: 14.307

View more
  148 in total

1.  Molecular basis of severe malaria.

Authors:  Kirk W Deitsch; Chetan E Chitnis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-07       Impact factor: 11.205

Review 2.  Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.

Authors:  Peter D Crompton; Jacqueline Moebius; Silvia Portugal; Michael Waisberg; Geoffrey Hart; Lindsey S Garver; Louis H Miller; Carolina Barillas-Mury; Susan K Pierce
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

Review 3.  The role of PfEMP1 adhesion domain classification in Plasmodium falciparum pathogenesis research.

Authors:  Joseph D Smith
Journal:  Mol Biochem Parasitol       Date:  2014-07-23       Impact factor: 1.759

4.  Cross-reactive immune responses as primary drivers of malaria chronicity.

Authors:  Eili Y Klein; Andrea L Graham; Manuel Llinás; Simon Levin
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

Review 5.  Activated protein C in neuroprotection and malaria.

Authors:  Laurent O Mosnier
Journal:  Curr Opin Hematol       Date:  2019-09       Impact factor: 3.284

6.  Infectious disease: Pathogenesis of cerebral malaria-a step forward.

Authors:  Sudhanshu S Pati; Saroj K Mishra
Journal:  Nat Rev Neurol       Date:  2012-07-24       Impact factor: 42.937

Review 7.  Malaria biology and disease pathogenesis: insights for new treatments.

Authors:  Louis H Miller; Hans C Ackerman; Xin-zhuan Su; Thomas E Wellems
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

8.  Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.

Authors:  Sylvie Briquet; Nadou Lawson-Hogban; Bertrand Boisson; Miguel P Soares; Roger Péronet; Leanna Smith; Robert Ménard; Michel Huerre; Salah Mécheri; Catherine Vaquero
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

9.  Management of severe malaria: enthusiasm for fluid resuscitation dampened by lung water.

Authors:  Hans Ackerman
Journal:  Crit Care Med       Date:  2013-04       Impact factor: 7.598

10.  Protein C system defects inflicted by the malaria parasite protein PfEMP1 can be overcome by a soluble EPCR variant.

Authors:  Jens E V Petersen; Eveline A M Bouwens; Ibai Tamayo; Louise Turner; Christian W Wang; Monique Stins; Thor G Theander; José Hermida; Laurent O Mosnier; Thomas Lavstsen
Journal:  Thromb Haemost       Date:  2015-07-09       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.